Concepedia
Statistics
Publications
22
Citations
618
H-Index
16
Active since
2013
Affiliations
Peking University(Current)
Sun Yat-sen University
Capital Medical University
Guangzhou Eighth People's Hospital
Fudan University
Quanmin Li is an author at Peking University specializing in diabetes, medicine, and drug discovery.
Top concepts
DiabetesMedicinePharmacologyDrug DiscoveryPharmacotherapyMetabolic Syndrome
Publications per year
2013–2024
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Dalong Zhu, Jianhua Ma, Jiao’e Zeng et al. · Nature Medicine · 2022 · 87 citations · Full text
Metabolic Syndrome, Diabetes Management, Placebo-controlled Phase 3 +8
Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial
Linong Ji, Xiaolin Tong, Hongyuan Wang et al. · PLoS ONE · 2013 · 84 citations · Full text
Prevalence of and Risk Factors for Peripheral Neuropathy in Chinese Patients With Diabetes: A Multicenter Cross-Sectional Study
Qi Pan, Quanmin Li, Wei Deng et al. · Frontiers in Endocrinology · 2018 · 47 citations · Full text
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)
Weiping Jia, Jianhua Ma, Heng Miao et al. · Science Bulletin · 2021 · 41 citations · Full text
MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase
Hui Zheng, Jian Wan, Yi Shan et al. · Theranostics · 2021 · 34 citations · Full text
Rows per page
1–5 of 22